Ana Carrero

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients.

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients.

Journal: Journal of biomedical science

Published: December 30, 2020

Near normalization of peripheral blood markers in HIV-infected patients on long-term suppressive antiretroviral therapy: a case-control study.

Near normalization of peripheral blood markers in HIV-infected patients on long-term suppressive antiretroviral therapy: a case-control study.

Journal: AIDS (London, England)

Published: August 16, 2020

Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients.

Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 18, 2020

Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients.

Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: January 09, 2020

European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study.

European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study.

Journal: Journal of translational medicine

Published: January 04, 2019

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR.

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR.

Journal: Scientific reports

Published: November 16, 2018

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).

Journal: Scientific reports

Published: September 05, 2018

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status.

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status.

Journal: Cells

Published: August 18, 2018

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.

Journal: AIDS (London, England)

Published: February 14, 2018

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis.

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis.

Journal: BMC infectious diseases

Published: August 08, 2017

Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

Journal: PloS one

Published: February 10, 2017

Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C.

Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C.

Journal: Open forum infectious diseases

Published: September 13, 2016

Showing 1-12 of 36

Last Updated: 09/26/2026